PMID: 1395825Oct 1, 1992Paper

Antithrombotic therapy for venous thromboembolic disease

Chest
T M HyersJ G Weg

Abstract

No abstract listed.

References

Jul 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·S N GitelS Wessler
Oct 18, 1979·The New England Journal of Medicine·R HullP Armstrong
Feb 1, 1978·American Heart Journal·M J Boekhout-MussertE A Loeliger
May 1, 1978·British Journal of Haematology·T L SimonL A Harker
Feb 1, 1979·American Heart Journal·J R Wilson, J Lampman
Jul 1, 1977·British Journal of Haematology·D HeidenR Rodvien
Jul 29, 1976·The New England Journal of Medicine·R B BabcockW B Scharfman
May 15, 1975·The New England Journal of Medicine·E W SalzmanR Rosenberg
Apr 1, 1976·Circulation·J HirshW L Yung
Jun 27, 1991·The New England Journal of Medicine·J Hirsh
Aug 1, 1991·Journal of the American College of Cardiology·S J ConnollyC Joyner
Feb 1, 1991·The Annals of Thoracic Surgery·G MeyerP Even
May 30, 1991·The New England Journal of Medicine·J Hirsh
Jun 1, 1990·Circulation·K M MoserP F Fedullo
Nov 29, 1990·The New England Journal of Medicine·UNKNOWN Boston Area Anticoagulation Trial for Atrial Fibrillation InvestigatorsJ Philip Kistler
Feb 15, 1990·The New England Journal of Medicine·J N SaourA S Gallus
Mar 1, 1990·Radiology·G S Dorfman
Mar 22, 1990·The New England Journal of Medicine·UNKNOWN Stroke Prevention in Atrial Fibrillation Study Group Investigators
Mar 1, 1985·British Journal of Obstetrics and Gynaecology·T T LaoB N Walters
Aug 15, 1989·Annals of Internal Medicine·R H WhiteR P Hartling

❮ Previous
Next ❯

Citations

Oct 1, 1993·Journal of General Internal Medicine·B M ReillyT Nieman
Jun 1, 1995·Journal of General Internal Medicine·H N LeeP Powers
Aug 1, 1996·Cardiovascular Surgery : Official Journal of the International Society for Cardiovascular Surgery·N MillerN M Sheiner
Jan 1, 1995·The American Journal of Medicine·R L Hirsch
Dec 21, 2000·British Journal of Haematology·S Kitchen
Jul 21, 1998·Journal of General Internal Medicine·J WhittleA R Localio
Dec 19, 2000·Journal of General Internal Medicine·D A GanzJ Avorn
Jun 30, 1994·The New England Journal of Medicine·J J O'MearaS M Downs
Jun 30, 1994·The New England Journal of Medicine·J P Kassirer
Dec 1, 1994·The New England Journal of Medicine·S G Pauker, R I Kopelman
Dec 15, 1994·The New England Journal of Medicine·E E Weinmann, E W Salzman
Feb 6, 1997·The New England Journal of Medicine·D L Diuguid
May 5, 1999·Therapeutic Apheresis : Official Journal of the International Society for Apheresis and the Japanese Society for Apheresis·Y AsanumaK Koyama
Jun 1, 1993·The American Review of Respiratory Disease·P GirardD Grunenwald
Nov 1, 1995·Journal of Clinical Pharmacology·M Gibaldi, A K Wittkowsky
Jan 19, 2016·Journal of Thrombosis and Thrombolysis·Maureen A SmytheAnn K Wittkowsky
Aug 1, 1996·Clinical Orthopaedics and Related Research·K D MontgomeryD L Helfet
Jan 1, 1995·Angiology·A MarkelD Gaitini
Dec 12, 2001·Blood Reviews·V J Marder
Sep 1, 1994·Progress in Cardiovascular Diseases·G F Pineo, R D Hull

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.